Loring Wolcott & Coolidge Fiduciary Advisors LLP Jazz Pharmaceuticals PLC Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

  • $11.1 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$128.64 - $184.79 $2,058 - $2,956
-16 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$160.2 - $186.42 $2,563 - $2,982
16 New
16 $3,000
Q2 2020

Jul 30, 2020
SELL
$95.68 - $121.88 $16,744 - $21,329
-175 Closed
0 $0
Q3 2019

Nov 05, 2019
SELL
$125.18 - $143.24 $4,005 - $4,583
-32 Reduced 15.46%
175 $22,000
Q2 2019

Aug 09, 2019
BUY
$125.55 - $144.48 $4,017 - $4,623
32 Added 18.29%
207 $30,000
Q1 2019

Apr 08, 2019
BUY
$121.81 - $142.95 $21,316 - $25,016
175 New
175 $25,000

Others Institutions Holding JAZZ

# of Institutions
512
Shares Held
57.5M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email